Tarsons Invests EUR 300,000 in Singapore Subsidiary

Tarsons Products Limited completed a EUR 300,000 equity investment in its wholly-owned Singapore subsidiary, Tarsons Life Science Pte. Ltd.
The investment involves subscribing to 100 equity shares at EUR 3,000 per share to fund loan repayments and operational expenses.
This transaction is a related party transaction conducted at arm's length, with no change in the subsidiary's wholly-owned status.
The subsidiary is a non-operating financial holding company incorporated in November 2023 and has reported nil turnover since inception.